<HTML>
<HEAD>
<TITLE>MIMEDX GROUP, INC.</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>As filed with the Securities and Exchange Commission on August 29,
2008</B></DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 1pt"><B>Registration No. 333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>
</DIV>

<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM S-8</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>REGISTRATION STATEMENT<BR>
UNDER<BR>
THE SECURITIES ACT OF 1933</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>MIMEDX GROUP, INC.</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="48%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Florida</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>26-2792552</B></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or other jurisdiction of incorporation)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(I.R.S. Employer Identification Number)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><B>1234 Airport Road, Suite&nbsp;105</B></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><B>Destin, Florida</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>32541</B></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(Address of principal executive offices)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Zip Code)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>(850)&nbsp;269-0000</B><BR>
Registrant&#146;s telephone number, including area code</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>MiMedx Group, Inc. Assumed 2006 Stock Incentive Plan</B></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>MiMedx Group, Inc. Amended and Restated Assumed 2005 Stock Plan<BR>
(formerly the SpineMedica Corp. 2005 Employee, Director and Consultant Stock Plan)</B></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>MiMedx, Inc. 2007 Assumed Stock Plan</B><BR>
<FONT style="border-bottom: 1px solid #000000"><B>(formerly the SpineMedica Corp. 2007 Stock Incentive Plan)</B></FONT><BR>
(Full title of the plan)</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Thomas W. D&#146;Alonzo<BR>
Chief Executive Officer<BR>
MiMedx Group, Inc.<BR>
1234 Airport Road, Suite&nbsp;105<BR>
Destin, Florida 32541</B><BR>
<FONT style="border-bottom: 1px solid #000000"><B>(850)&nbsp;269-0000</B></FONT><BR>
(Name, address and telephone number, including area code,<BR>
of agent for service)</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See definitions of &#147;large accelerated
filer,&#148; &#147;accelerated filer,&#148; and &#147;smaller reporting company&#148; in Rule&nbsp;12b-2 of the Exchange
Act. (Check one):
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<TR style="font-size: 6pt">
    <TD width="22%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">Large accelerated filer <FONT face="Wingdings">&#111;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Accelerated filer <FONT face="Wingdings">&#111;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Non-accelerated filer <FONT face="Wingdings">&#111;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">Smaller reporting company <FONT face="Wingdings">&#254;</FONT></TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><FONT style="white-space: nowrap">(Do not check if a smaller reporting company)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">CALCULATION OF REGISTRATION FEE</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="50%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="18%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR><TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="15" style="border-bottom: 3px double #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Proposed Maximum</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Proposed Maximum</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>
    <TD nowrap align="center"><B>Title of Securities to be</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Amount to be</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Offering Price per</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Aggregate Offering</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Amount of</B></TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 0px solid #000000"><B>Registered</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 0px solid #000000"><B>Registered (1)</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Share</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Price</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 0px solid #000000"><B>Registration Fee</B></TD>
    <TD width="1%">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
                    <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock $0.001 par value per share(2)</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">2,393,125</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$5.10(2)</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$12,204,937.50(2)</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$479.65</TD>
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock $0.001 par value per share(3)</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">3,106,875</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$2.42(3)</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$7,518,637.50(3)</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$295.48</TD>
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock $0.001 par value per share(4)</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">1,008,750</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$1.80(4)</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$1,815,750.00(4)</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$71.36</TD>
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock $0.001 par value per share(5)</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">126,250</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$1.80(5)</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$227,250(5)</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$8.93</TD>
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">TOTAL:</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">6,635,000</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$21,766,575.00</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>

<TD align="center" valign="bottom" style="border-top: 2px solid #000000">$855.43</TD>
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="15" style="border-top: 3px double #000000">&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<DIV style="margin-top: 3pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">(1)</TD>
    <TD>&nbsp;</TD>
    <TD>This registration statement on Form S-8 (this &#147;Registration Statement&#148;) is being filed to
register (i)&nbsp;2,393,125&nbsp;shares of common stock, U.S.$0.001 par value per share of MiMedx
Group, Inc. (the &#147;Company&#148;) (&#147;Common Stock&#148;) available for issuance under the MiMedx Group,
Inc. Assumed 2006 Stock Incentive Plan (the &#147;Incentive
Plan&#148;), (ii)&nbsp;3,106,875&nbsp;shares of
Common Stock issuable upon exercise of options previously granted and presently outstanding
under the Incentive Plan, (iii)&nbsp;1,008,750 shares of Common Stock issuable upon exercise of
options previously granted and presently outstanding under the MiMedx Group, Inc. Amended and
Restated Assumed 2005 Stock Plan (formerly the SpineMedica Corp. 2005 Employee, Director and
Consultant Stock Plan) (the &#147;2005 Assumed Plan&#148;), and (iv)&nbsp;126,250 shares of Common Stock
issuable upon exercise of options previously granted and presently outstanding under the
MiMedx, Inc. 2007 Assumed Stock Plan (formerly the SpineMedica Corp. 2007 Stock Incentive
Plan) (the &#147;2007 Assumed Plan,&#148; and together with the Incentive Plan and the 2005 Assumed
Plan, collectively, the &#147;Plans&#146;). This Registration Statement also registers additional
securities to be offered or issued upon adjustment or changes made to the registered
securities by reason of any stock splits, stock dividends or similar transactions as permitted
by Rule 416(a) and Rule 416(b) under the Securities Act of 1933, as amended (the &#147;Securities
Act&#148;).</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(2)</TD>
    <TD>&nbsp;</TD>
    <TD>Represents shares of Common Stock issuable upon exercise of options that have not yet been
granted as of the date of this Registration Statement under the Incentive Plan. The proposed
maximum offering price per share and proposed maximum offering price have been calculated as
to 2,393,125
shares under the Incentive Plan, estimated solely for the purpose of calculating
the registration fee pursuant to Rule 457(c) and 457(h) under the Securities Act, based upon
$5.10 per share, which is the closing price for the Common Stock reported on the OTCBB on August
25, 2008.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(3)</TD>
    <TD>&nbsp;</TD>
    <TD>Represents shares of Common Stock issuable upon exercise of outstanding options under the
Incentive Plan as of the date of this Registration Statement. The proposed maximum offering
price per share and proposed maximum offering price have been
calculated as to 3,106,875 shares of Common Stock issuable upon exercise of options previously granted and presently outstanding
under the Incentive Plan, determined in accordance with Rule&nbsp;457(h)(1) under the Securities
Act.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(4)</TD>
    <TD>&nbsp;</TD>
    <TD>Represents shares of Common Stock issuable upon exercise of outstanding options under the
2005 Assumed Plan as of the date of this Registration Statement. The proposed maximum offering
price per share and proposed maximum offering price have been calculated as to 1,008,750
shares of Common Stock issuable upon exercise of options previously granted and presently
outstanding under the 2005 Assumed Plan, determined in accordance with Rule&nbsp;457(h)(1) under
the Securities Act.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(5)</TD>
    <TD>&nbsp;</TD>
    <TD>Represents shares of Common Stock issuable upon exercise of outstanding options under the
2007 Assumed Plan as of the date of this Registration Statement. The proposed maximum offering
price per share and proposed maximum offering price have been calculated as to 126,250 shares
of Common Stock issuable upon exercise of options previously granted and presently outstanding
under the 2007 Assumed Plan.</TD>
</TR>

</TABLE>
</DIV>


<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>

<DIV style="font-family: 'Times New Roman',Times,serif">








<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD colspan="9"><A HREF="#000">PART I</A></TD></TR>
<TR><TD colspan="9"><A HREF="#001">PART II</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#002">Item&nbsp;3. Incorporation of Documents by Reference</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#003">Item&nbsp;4. Description of Securities</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#004">Item&nbsp;5. Interests of Named Experts and Counsel</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#005">Item&nbsp;6. Indemnification of Directors and Officers</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#006">Item&nbsp;7. Exemption from Registration Claimed</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#007">Item&nbsp;8. Exhibits</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#008">Item&nbsp;9. Undertakings</A></TD></TR>
<TR><TD colspan="9"><A HREF="#009">SIGNATURES</A></TD></TR>
<TR><TD colspan="9"><A HREF="#010">EXHIBIT INDEX</A></TD></TR>
<TR><TD colspan="9"><A HREF="g14948exv5.htm">EX-5 OPINION OF WOMBLE CARLYLE SANDRIDGE & RICE PLLC</A></TD></TR>
<TR><TD colspan="9"><A HREF="g14948exv10w4.htm">EX-10.4 AMENDED AND RESTATED ASSUMED 2005 STOCK PLAN</A></TD></TR>
<TR><TD colspan="9"><A HREF="g14948exv23w2.htm">EX-23.2 CONSENT OF CHERRY BEKAERT & HOLLAND, L.L.P.</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>




<!-- link1 "PART I" -->
<DIV align="left"><A NAME="000"></A></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>PART I</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The documents containing the information specified in Part&nbsp;I of this Registration Statement
will be sent or given to participants in the Plans, as applicable, as specified under Rule
428(b)(1) under the Securities Act. Such documents are not required to be, and are not being, filed
by the Company with the Securities and Exchange Commission (the &#147;Commission&#148;) either as part of
this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule&nbsp;424 under
the Securities Act. Such documents, together with the documents incorporated by reference herein
pursuant to Item&nbsp;3 of Part&nbsp;II of this Registration Statement, constitute a prospectus that meets
the requirements of Section 10(a) of the Securities Act.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- link1 "PART II" -->
<DIV align="left"><A NAME="001"></A></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>PART II</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B>

</DIV>
<!-- link2 "Item&nbsp;3. Incorporation of Documents by Reference" -->
<DIV align="left"><A NAME="002"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U><B>Item&nbsp;3</B></U><B>. </B><U><B>Incorporation of Documents by Reference</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following documents filed by the Company with the Commission pursuant to the Securities
Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;) are incorporated herein by reference:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company&#146;s Annual Report on Form 10-K for the fiscal year ended March&nbsp;31, 2008,
filed with the Commission on June&nbsp;27, 2008 and Amendment No.&nbsp;1 thereto on Form 10-K/A filed
on July&nbsp;29, 2008; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Company&#146;s Current Reports on Form 8-K filed with the Commission on April&nbsp;2,
2008, April&nbsp;4, 2008, May&nbsp;1, 2008, May&nbsp;29, 2008, June&nbsp;13, 2008, and July&nbsp;15, 2008.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The Company&#146;s Quarterly Report on Form 10-Q filed with the Commission on August&nbsp;14,
2008.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) The description of the Company&#146;s Common Stock, contained in the Company&#146;s
registration statement on Form 10-SB filed with the Commission on March&nbsp;3, 2003, including
any amendment or report filed for the purpose of updating such description.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All documents subsequently filed by the Company pursuant to Sections&nbsp;13(a), 13(c), 14 and
15(d) of the Exchange Act prior to the filing of a post-effective amendment which indicates that
all securities offered hereby have been sold or which deregisters all securities remaining unsold,
shall be deemed to be incorporated by reference herein and to be a part hereof from the date of the
filing of such documents.
</DIV>

<!-- link2 "Item&nbsp;4. Description of Securities" -->
<DIV align="left"><A NAME="003"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U><B>Item&nbsp;4</B></U><B>. </B><U><B>Description of Securities</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable.
</DIV>

<!-- link2 "Item&nbsp;5. Interests of Named Experts and Counsel" -->
<DIV align="left"><A NAME="004"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U><B>Item&nbsp;5</B></U><B>. </B><U><B>Interests of Named Experts and Counsel</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The legality of the securities offered hereby has been passed upon by the firm of Womble
Carlyle Sandridge &#038; Rice, PLLC, counsel to the Company. Attorneys of the firm beneficially hold an
aggregate of approximately 192,439 shares of Common Stock of the Company.
</DIV>
<!-- link2 "Item&nbsp;6. Indemnification of Directors and Officers" -->
<DIV align="left"><A NAME="005"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U><B>Item&nbsp;6</B></U><B>. </B><U><B>Indemnification of Directors and Officers</B></U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company is a Florida corporation. The following summary is qualified in its entirety
by reference to the complete text of the Florida Business Corporation Act (the &#147;FBCA&#148;), the
Company&#146;s Articles of Incorporation, and the Company&#146;s Bylaws.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under Section&nbsp;607.0850(1) of the FBCA, a corporation may indemnify any of its directors and
officers against expenses (including attorneys&#146; fees), judgments, fines and amounts paid in
settlement actually and reasonably incurred by such person in connection with such action, suit or
proceeding (including any appeal thereof) (i)&nbsp;if such person acted in good faith and in a manner he
or she reasonably believed to be in, or not opposed to, the best interests of the corporation, and
(ii)&nbsp;with respect to any criminal action or proceeding, he or she had no reasonable cause to
believe his or her conduct was unlawful. In actions brought by or in the right of the corporation,
however, Section&nbsp;607.0850(2) provides that no indemnification shall be made in respect of any
claim, issue or matter as to which the director or officer shall have been adjudged to be liable
unless, and only to the extent that, the court in which such proceeding was brought, or any other
court of competent jurisdiction, shall determine upon application that, despite the adjudication of
liability but in view of all circumstances of the case, such person is fairly and reasonably
entitled to indemnity for such expenses which such court shall deem proper. Article&nbsp;8 of the
Registrant&#146;s Articles of Incorporation and Section&nbsp;9 of Article&nbsp;VIII of the Registrant&#146;s Bylaws
require that, if in the judgment of the majority of the Board of Directors (excluding from such
majority any director under consideration for indemnification) the criteria set forth under Section
607.0850 have been met, then the Registrant shall indemnify its directors and officers for certain
liabilities incurred in the performance of their duties on behalf of the Registrant in the manner
and to the extent contemplated by Section&nbsp;607.0850 of the FBCA (formerly Section&nbsp;607.014 of the
Florida General Corporation Act).
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has purchased insurance to insure (i)&nbsp;the Company&#146;s directors and officers
against damages from actions and claims incurred in the course of their duties, and (ii)&nbsp;the
Company against expenses incurred in defending lawsuits arising from certain alleged acts of its
directors and officers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company&#146;s Board of Directors has approved a form of Indemnification Agreement to be
entered into by the Company with each of its directors and executive officers (as defined by,
and determined in accordance with, Section&nbsp;16 and Rule&nbsp;3b-7 of the Exchange Act) and authorized it
to enter into separate Indemnification Agreements with each of its directors and each of its
executive officers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Indemnification Agreements provide, among other things, that the Company will indemnify
such directors and executive officers to the fullest extent permitted by Florida law for claims
arising out of, or in connection with, the indemnitee&#146;s service to the Company. The
indemnification is subject to limitations and other conditions specified in the Indemnification
Agreements. To the extent that a change in Florida law, whether by statute or judicial decision,
permits greater indemnification or advancement of expenses than would be afforded currently under
the Company&#146;s Articles of Incorporation, Bylaws and the Indemnification Agreement, the
indemnitee will receive under the Indemnification Agreement the greater benefits so afforded by
such change.
</DIV>
<!-- link2 "Item&nbsp;7. Exemption from Registration Claimed" -->
<DIV align="left"><A NAME="006"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U><B>Item&nbsp;7</B></U><B>. </B><U><B>Exemption from Registration Claimed</B></U><B>.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable.
</DIV>

<!-- link2 "Item&nbsp;8. Exhibits" -->
<DIV align="left"><A NAME="007"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U><B>Item&nbsp;8</B></U><B>. </B><U><B>Exhibits</B></U><B>.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following exhibits are filed as a part of this Registration Statement:
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="90%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Description</B></TD>
</TR>

<TR style="font-size: 10pt">
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Articles of Incorporation of MiMedx Group, Inc. (incorporated by
reference to Exhibit&nbsp;3.1 to the Company&#146;s Current Report on Form&nbsp;8-K
filed with the Commission on April&nbsp;2, 2008)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Bylaws of MiMedx Group, Inc., effective February&nbsp;29, 2008 (incorporated
by reference to Exhibit&nbsp;3.2 to the Company&#146;s Current Report on Form&nbsp;8-K
filed with the Commission on April&nbsp;2, 2008)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">5
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Womble Carlyle Sandridge &#038; Rice, PLLC</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">10.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">MiMedx Group, Inc. Assumed 2006 Stock Incentive Plan (incorporated by
reference to Exhibit&nbsp;10.1 to the Company&#146;s Current Report on Form&nbsp;8-K
filed with the Commission on February&nbsp;8, 2008)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">10.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Declaration of Amendment to MiMedx Group, Inc. Assumed 2006 Stock
Incentive Plan (incorporated by reference to Exhibit&nbsp;10.2 to the
Company&#146;s Current Report on Form&nbsp;8-K filed with the Commission on
February&nbsp;8, 2008)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">10.3
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Declaration of Amendment to MiMedx Group, Inc. Assumed 2006 Stock
Incentive Plan (incorporated by reference to Exhibit&nbsp;10.66 to the
Company&#146;s Current Report on Form&nbsp;8-K filed with the Commission on July
15, 2008)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">10.4
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">MiMedx Group, Inc. Amended and Restated Assumed 2005 Stock Plan
(formerly the SpineMedica Corp. 2005 Employee, Director and Consultant
Stock Plan)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">10.5
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">MiMedx, Inc. Assumed 2007 Stock Plan (formerly the SpineMedica Corp.
2007 Stock Incentive Plan) (incorporated by reference to Exhibit&nbsp;10.9
to the Company&#146;s Current Report on Form&nbsp;8-K filed with the Commission
on February&nbsp;8, 2008)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">10.6
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Declaration of Amendment to MiMedx, Inc. Assumed 2007 Stock Plan
(formerly the SpineMedica Corp. 2007 Stock Incentive Plan)
(incorporated by reference to Exhibit&nbsp;10.10 to the Company&#146;s Current
Report on Form&nbsp;8-K filed with the Commission on February&nbsp;8, 2008)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Womble Carlyle Sandridge &#038; Rice, PLLC (included in Exhibit&nbsp;5)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Cherry, Bekaert &#038; Holland, L.L.P.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">24
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Power of Attorney (included in the signature page hereto)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<!-- link2 "Item&nbsp;9. Undertakings" -->
<DIV align="left"><A NAME="008"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U><B>Item&nbsp;9</B></U><B>. </B><U><B>Undertakings</B></U>.
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The undersigned registrant hereby undertakes:</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;To file, during any period in which offers or sales are being made, a post-effective
amendment to this Registration Statement:
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(i)&nbsp;To include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(ii)&nbsp;To reflect in the prospectus any facts or events arising after the effective date of
the Registration Statement (or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change in the information set
forth in the Registration Statement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(iii)&nbsp;To include any material information with respect to the plan of distribution not
previously disclosed in the Registration Statement or any material change to such
information in the Registration Statement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%"><U>provided</U>, <U>however</U>, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if
the registration statement is on Form S-8, and the information required to be included in a
post-effective amendment by those paragraphs is contained in reports filed with or furnished
to the Commission by the Company pursuant to Section&nbsp;13 or Section 15(d) of the Exchange Act
that are incorporated by reference in the Registration Statement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;That, for the purpose of determining any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;To remove from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the offering.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company hereby undertakes that, for purposes of determining any liability under the
Securities Act, each filing of the Company&#146;s annual report pursuant to Section 13(a) or
Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit
plan&#146;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by
reference in the Registration Statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial bona fide offering thereof.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">(c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Insofar as indemnification for liabilities arising under the Securities Act may be permitted
to directors, officers and controlling persons of the Company pursuant to the foregoing
provisions, or otherwise, the Company has been advised that in the opinion of the Commission
such indemnification is against public policy as expressed in the Securities Act and is,
therefore, unenforceable. In the event that a claim for indemnification against such
liabilities (other than the payment by the Company of expenses incurred or paid by a director,
officer or controlling person of the Company in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in connection with the
securities being registered, the Company will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the
Securities Act and will be governed by the final adjudication of such issue.</TD>
</TR>


</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>
<!-- link1 "SIGNATURES" -->
<DIV align="left"><A NAME="009"></A></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act, MiMedx Group, Inc. certifies that it has
reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has
duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Marietta, State of Georgia, on this 28<SUP style="font-size: 85%; vertical-align: text-top">th </SUP>day of August,
2008.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left"><B>MIMEDX GROUP, INC.</B><BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ John C. Thomas, Jr.
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">John C. Thomas, Jr.&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Chief Financial Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>POWER OF ATTORNEY</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of the undersigned, being a director and/or officer of MiMedx Group, Inc. (the
&#147;Company&#148;), hereby nominates, constitutes and appoints Thomas W. D&#146;Alonzo and John C. Thomas, or
any one of them severally to be his true and lawful attorney-in-fact and agent and to sign in his
name and on his behalf in any and all capacities stated below, and to file with the Securities and
Exchange Commission (the &#147;Commission&#148;), a Registration Statement on Form S-8 (the &#147;Registration
Statement&#148;) relating to the issuance of certain shares of the common stock, $.001 par value, of the
Company in connection with the MiMedx Group, Inc. Assumed 2006 Stock Incentive Plan, the MiMedx, Inc. 2005 Assumed Stock Plan (formerly the SpineMedica Corp. 2005
Employee, Director and Consultant Stock Plan), and the MiMedx, Inc. Assumed 2007 Stock Plan
(formerly the SpineMedica Corp. 2007 Stock Incentive Plan), and to file any and all amendments,
including post-effective amendments, exhibits and other documents and instruments in connection
therewith, to the Registration Statement, making such changes in the Registration Statement as such
attorney-in-fact and agent deems appropriate, and generally to do all such things on his behalf in
any and all capacities stated below to enable the Company to comply with the provisions of the
Securities Act of 1933, as amended (the &#147;Securities Act&#148;), and all requirements of the Commission.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act, this Registration Statement has been
signed by the following persons in the capacities indicated as of August&nbsp;28<SUP style="font-size: 85%; vertical-align: text-top">th</SUP>, 2008.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Thomas W. D&#146;Alonzo
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ John C. Thomas, Jr.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Name: Thomas W. D&#146;Alonzo
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Name: John C. Thomas, Jr.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Title: Chief Executive Officer
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title: Chief Financial Officer and Secretary</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:30px; text-indent:-0px">(principal
executive officer and Director)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><DIV style="margin-left:30px; text-indent:-0px">(principal
financial and accounting officer)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Steve Gorlin
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Name: Steve Gorlin
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Kurt M. Eichler
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Name: Kurt M. Eichler
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Title: Director
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title: Director</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Charles E. Koob
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Name: Charles E. Koob
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Larry W. Papasan
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Name: Larry W. Papasan
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Title: Director
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title: Director</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Ronald G. Wallace
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Name: Ronald G. Wallace
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Title: Director</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- link1 "EXHIBIT INDEX" -->
<DIV align="left"><A NAME="010"></A></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXHIBIT INDEX</B></DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="90%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Description</B></TD>
</TR>

<TR style="font-size: 10pt">
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Articles of Incorporation of MiMedx Group, Inc. (incorporated by
reference to Exhibit&nbsp;3.1 to the Company&#146;s Current Report on Form&nbsp;8-K
filed with the Commission on April&nbsp;2, 2008)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Bylaws of MiMedx Group, Inc., effective February&nbsp;29, 2008 (incorporated
by reference to Exhibit&nbsp;3.2 to the Company&#146;s Current Report on Form&nbsp;8-K
filed with the Commission on April&nbsp;2, 2008)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">5
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Womble Carlyle Sandridge &#038; Rice, PLLC</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">10.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">MiMedx Group, Inc. Assumed 2006 Stock Incentive Plan (incorporated by
reference to Exhibit&nbsp;10.1 to the Company&#146;s Current Report on Form&nbsp;8-K
filed with the Commission on February&nbsp;8, 2008)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">10.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Declaration of Amendment to MiMedx Group, Inc. Assumed 2006 Stock
Incentive Plan (incorporated by reference to Exhibit&nbsp;10.2 to the
Company&#146;s Current Report on Form&nbsp;8-K filed with the Commission on
February&nbsp;8, 2008)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">10.3
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Declaration of Amendment to MiMedx Group, Inc. Assumed 2006 Stock
Incentive Plan (incorporated by reference to Exhibit&nbsp;10.66 to the
Company&#146;s Current Report on Form&nbsp;8-K filed with the Commission on July
15, 2008)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">10.4
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">MiMedx Group, Inc. Amended and Restated Assumed 2005 Stock Plan
(formerly the SpineMedica Corp. 2005 Employee, Director and Consultant
Stock Plan)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">10.5
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">MiMedx, Inc. Assumed 2007 Stock Plan (formerly the SpineMedica Corp.
2007 Stock Incentive Plan) (incorporated by reference to Exhibit&nbsp;10.9
to the Company&#146;s Current Report on Form&nbsp;8-K filed with the Commission
on February&nbsp;8, 2008)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">10.6
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Declaration of Amendment to MiMedx, Inc. Assumed 2007 Stock Plan
(formerly the SpineMedica Corp. 2007 Stock Incentive Plan)
(incorporated by reference to Exhibit&nbsp;10.10 to the Company&#146;s Current
Report on Form&nbsp;8-K filed with the Commission on February&nbsp;8, 2008)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Womble Carlyle Sandridge &#038; Rice, PLLC (included in Exhibit&nbsp;5)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Cherry, Bekaert &#038; Holland, L.L.P.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">24
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Power of Attorney (included in the signature page hereto)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "g14948sv8.htm", "description": "MIMEDX GROUP, INC.", "secsgml_size_bytes": 63076}]
{"company-data": {"conformed-name": "MIMEDX GROUP, INC.", "cik": "0001376339", "assigned-sic": "3841", "irs-number": "900300868", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-153255", "film-number": "081048248"}, "business-address": {"street1": "1234 AIRPORT ROAD", "street2": "SUITE 105", "city": "DESTIN", "state": "FL", "zip": "32541", "phone": "850-269-0000"}, "mail-address": {"street1": "1234 AIRPORT ROAD", "street2": "SUITE 105", "city": "DESTIN", "state": "FL", "zip": "32541"}, "former-company": {"former-conformed-name": "Alynx, Co.", "date-changed": "20060922"}}
MIMEDX GROUP, INC.
Table of Contents
As filed with the Securities and Exchange Commission on August 29,
2008
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
MIMEDX GROUP, INC.
(Exact name of registrant as specified in its charter)
Florida
26-2792552
(State or other jurisdiction of incorporation)
(I.R.S. Employer Identification Number)
1234 Airport Road, Suite 105
Destin, Florida
32541
(Address of principal executive offices)
(Zip Code)
(850) 269-0000
Registrant's telephone number, including area code
MiMedx Group, Inc. Assumed 2006 Stock Incentive Plan
MiMedx Group, Inc. Amended and Restated Assumed 2005 Stock Plan
(formerly the SpineMedica Corp. 2005 Employee, Director and Consultant Stock Plan)
MiMedx, Inc. 2007 Assumed Stock Plan
(formerly the SpineMedica Corp. 2007 Stock Incentive Plan)
(Full title of the plan)
Thomas W. D'Alonzo
Chief Executive Officer
MiMedx Group, Inc.
1234 Airport Road, Suite 105
Destin, Florida 32541
(850) 269-0000
(Name, address and telephone number, including area code,
of agent for service)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See definitions of "large accelerated
filer," "accelerated filer," and "smaller reporting company" in Rule 12b-2 of the Exchange
Act. (Check one):
Large accelerated filer
o
Accelerated filer
o
Non-accelerated filer
o
Smaller reporting company
þ
(Do not check if a smaller reporting company)
CALCULATION OF REGISTRATION FEE
Proposed Maximum
Proposed Maximum
Title of Securities to be
Amount to be
Offering Price per
Aggregate Offering
Amount of
Registered
Registered (1)
Share
Price
Registration Fee
Common Stock $0.001 par value per share(2)
2,393,125
$5.10(2)
$12,204,937.50(2)
$479.65
Common Stock $0.001 par value per share(3)
3,106,875
$2.42(3)
$7,518,637.50(3)
$295.48
Common Stock $0.001 par value per share(4)
1,008,750
$1.80(4)
$1,815,750.00(4)
$71.36
Common Stock $0.001 par value per share(5)
126,250
$1.80(5)
$227,250(5)
$8.93
TOTAL:
6,635,000
$21,766,575.00
$855.43
(1)
This registration statement on Form S-8 (this "Registration Statement") is being filed to
register (i) 2,393,125 shares of common stock, U.S.$0.001 par value per share of MiMedx
Group, Inc. (the "Company") ("Common Stock") available for issuance under the MiMedx Group,
Inc. Assumed 2006 Stock Incentive Plan (the "Incentive
Plan"), (ii) 3,106,875 shares of
Common Stock issuable upon exercise of options previously granted and presently outstanding
under the Incentive Plan, (iii) 1,008,750 shares of Common Stock issuable upon exercise of
options previously granted and presently outstanding under the MiMedx Group, Inc. Amended and
Restated Assumed 2005 Stock Plan (formerly the SpineMedica Corp. 2005 Employee, Director and
Consultant Stock Plan) (the "2005 Assumed Plan"), and (iv) 126,250 shares of Common Stock
issuable upon exercise of options previously granted and presently outstanding under the
MiMedx, Inc. 2007 Assumed Stock Plan (formerly the SpineMedica Corp. 2007 Stock Incentive
Plan) (the "2007 Assumed Plan," and together with the Incentive Plan and the 2005 Assumed
Plan, collectively, the "Plans'). This Registration Statement also registers additional
securities to be offered or issued upon adjustment or changes made to the registered
securities by reason of any stock splits, stock dividends or similar transactions as permitted
by Rule 416(a) and Rule 416(b) under the Securities Act of 1933, as amended (the "Securities
Act").
(2)
Represents shares of Common Stock issuable upon exercise of options that have not yet been
granted as of the date of this Registration Statement under the Incentive Plan. The proposed
maximum offering price per share and proposed maximum offering price have been calculated as
to 2,393,125
shares under the Incentive Plan, estimated solely for the purpose of calculating
the registration fee pursuant to Rule 457(c) and 457(h) under the Securities Act, based upon
$5.10 per share, which is the closing price for the Common Stock reported on the OTCBB on August
25, 2008.
(3)
Represents shares of Common Stock issuable upon exercise of outstanding options under the
Incentive Plan as of the date of this Registration Statement. The proposed maximum offering
price per share and proposed maximum offering price have been
calculated as to 3,106,875 shares of Common Stock issuable upon exercise of options previously granted and presently outstanding
under the Incentive Plan, determined in accordance with Rule 457(h)(1) under the Securities
Act.
(4)
Represents shares of Common Stock issuable upon exercise of outstanding options under the
2005 Assumed Plan as of the date of this Registration Statement. The proposed maximum offering
price per share and proposed maximum offering price have been calculated as to 1,008,750
shares of Common Stock issuable upon exercise of options previously granted and presently
outstanding under the 2005 Assumed Plan, determined in accordance with Rule 457(h)(1) under
the Securities Act.
(5)
Represents shares of Common Stock issuable upon exercise of outstanding options under the
2007 Assumed Plan as of the date of this Registration Statement. The proposed maximum offering
price per share and proposed maximum offering price have been calculated as to 126,250 shares
of Common Stock issuable upon exercise of options previously granted and presently outstanding
under the 2007 Assumed Plan.
TABLE OF CONTENTS
PART I
PART II
Item 3. Incorporation of Documents by Reference
Item 4. Description of Securities
Item 5. Interests of Named Experts and Counsel
Item 6. Indemnification of Directors and Officers
Item 7. Exemption from Registration Claimed
Item 8. Exhibits
Item 9. Undertakings
SIGNATURES
EXHIBIT INDEX
EX-5 OPINION OF WOMBLE CARLYLE SANDRIDGE & RICE PLLC
EX-10.4 AMENDED AND RESTATED ASSUMED 2005 STOCK PLAN
EX-23.2 CONSENT OF CHERRY BEKAERT & HOLLAND, L.L.P.
Table of Contents
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
The documents containing the information specified in Part I of this Registration Statement
will be sent or given to participants in the Plans, as applicable, as specified under Rule
428(b)(1) under the Securities Act. Such documents are not required to be, and are not being, filed
by the Company with the Securities and Exchange Commission (the "Commission") either as part of
this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under
the Securities Act. Such documents, together with the documents incorporated by reference herein
pursuant to Item 3 of Part II of this Registration Statement, constitute a prospectus that meets
the requirements of Section 10(a) of the Securities Act.
2
Table of Contents
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3
.
Incorporation of Documents by Reference
.
The following documents filed by the Company with the Commission pursuant to the Securities
Exchange Act of 1934, as amended (the "Exchange Act") are incorporated herein by reference:
(a) The Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2008,
filed with the Commission on June 27, 2008 and Amendment No. 1 thereto on Form 10-K/A filed
on July 29, 2008; and
(b) The Company's Current Reports on Form 8-K filed with the Commission on April 2,
2008, April 4, 2008, May 1, 2008, May 29, 2008, June 13, 2008, and July 15, 2008.
(c) The Company's Quarterly Report on Form 10-Q filed with the Commission on August 14,
2008.
(d) The description of the Company's Common Stock, contained in the Company's
registration statement on Form 10-SB filed with the Commission on March 3, 2003, including
any amendment or report filed for the purpose of updating such description.
All documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and
15(d) of the Exchange Act prior to the filing of a post-effective amendment which indicates that
all securities offered hereby have been sold or which deregisters all securities remaining unsold,
shall be deemed to be incorporated by reference herein and to be a part hereof from the date of the
filing of such documents.
Item 4
.
Description of Securities
.
Not applicable.
Item 5
.
Interests of Named Experts and Counsel
.
The legality of the securities offered hereby has been passed upon by the firm of Womble
Carlyle Sandridge & Rice, PLLC, counsel to the Company. Attorneys of the firm beneficially hold an
aggregate of approximately 192,439 shares of Common Stock of the Company.
Item 6
.
Indemnification of Directors and Officers
.
The Company is a Florida corporation. The following summary is qualified in its entirety
by reference to the complete text of the Florida Business Corporation Act (the "FBCA"), the
Company's Articles of Incorporation, and the Company's Bylaws.
Under Section 607.0850(1) of the FBCA, a corporation may indemnify any of its directors and
officers against expenses (including attorneys' fees), judgments, fines and amounts paid in
settlement actually and reasonably incurred by such person in connection with such action, suit or
proceeding (including any appeal thereof) (i) if such person acted in good faith and in a manner he
or she reasonably believed to be in, or not opposed to, the best interests of the corporation, and
(ii) with respect to any criminal action or proceeding, he or she had no reasonable cause to
believe his or her conduct was unlawful. In actions brought by or in the right of the corporation,
however, Section 607.0850(2) provides that no indemnification shall be made in respect of any
claim, issue or matter as to which the director or officer shall have been adjudged to be liable
unless, and only to the extent that, the court in which such proceeding was brought, or any other
court of competent jurisdiction, shall determine upon application that, despite the adjudication of
liability but in view of all circumstances of the case, such person is fairly and reasonably
entitled to indemnity for such expenses which such court shall deem proper. Article 8 of the
Registrant's Articles of Incorporation and Section 9 of Article VIII of the Registrant's Bylaws
require that, if in the judgment of the majority of the Board of Directors (excluding from such
majority any director under consideration for indemnification) the criteria set forth under Section
607.0850 have been met, then the Registrant shall indemnify its directors and officers for certain
liabilities incurred in the performance of their duties on behalf of the Registrant in the manner
and to the extent contemplated by Section 607.0850 of the FBCA (formerly Section 607.014 of the
Florida General Corporation Act).
3
Table of Contents
The Company has purchased insurance to insure (i) the Company's directors and officers
against damages from actions and claims incurred in the course of their duties, and (ii) the
Company against expenses incurred in defending lawsuits arising from certain alleged acts of its
directors and officers.
The Company's Board of Directors has approved a form of Indemnification Agreement to be
entered into by the Company with each of its directors and executive officers (as defined by,
and determined in accordance with, Section 16 and Rule 3b-7 of the Exchange Act) and authorized it
to enter into separate Indemnification Agreements with each of its directors and each of its
executive officers.
The Indemnification Agreements provide, among other things, that the Company will indemnify
such directors and executive officers to the fullest extent permitted by Florida law for claims
arising out of, or in connection with, the indemnitee's service to the Company. The
indemnification is subject to limitations and other conditions specified in the Indemnification
Agreements. To the extent that a change in Florida law, whether by statute or judicial decision,
permits greater indemnification or advancement of expenses than would be afforded currently under
the Company's Articles of Incorporation, Bylaws and the Indemnification Agreement, the
indemnitee will receive under the Indemnification Agreement the greater benefits so afforded by
such change.
Item 7
.
Exemption from Registration Claimed
.
Not applicable.
Item 8
.
Exhibits
.
The following exhibits are filed as a part of this Registration Statement:
Number
Description
4.1
Articles of Incorporation of MiMedx Group, Inc. (incorporated by
reference to Exhibit 3.1 to the Company's Current Report on Form 8-K
filed with the Commission on April 2, 2008)
4.2
Bylaws of MiMedx Group, Inc., effective February 29, 2008 (incorporated
by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K
filed with the Commission on April 2, 2008)
5
Opinion of Womble Carlyle Sandridge & Rice, PLLC
10.1
MiMedx Group, Inc. Assumed 2006 Stock Incentive Plan (incorporated by
reference to Exhibit 10.1 to the Company's Current Report on Form 8-K
filed with the Commission on February 8, 2008)
10.2
Declaration of Amendment to MiMedx Group, Inc. Assumed 2006 Stock
Incentive Plan (incorporated by reference to Exhibit 10.2 to the
Company's Current Report on Form 8-K filed with the Commission on
February 8, 2008)
10.3
Declaration of Amendment to MiMedx Group, Inc. Assumed 2006 Stock
Incentive Plan (incorporated by reference to Exhibit 10.66 to the
Company's Current Report on Form 8-K filed with the Commission on July
15, 2008)
10.4
MiMedx Group, Inc. Amended and Restated Assumed 2005 Stock Plan
(formerly the SpineMedica Corp. 2005 Employee, Director and Consultant
Stock Plan)
10.5
MiMedx, Inc. Assumed 2007 Stock Plan (formerly the SpineMedica Corp.
2007 Stock Incentive Plan) (incorporated by reference to Exhibit 10.9
to the Company's Current Report on Form 8-K filed with the Commission
on February 8, 2008)
10.6
Declaration of Amendment to MiMedx, Inc. Assumed 2007 Stock Plan
(formerly the SpineMedica Corp. 2007 Stock Incentive Plan)
(incorporated by reference to Exhibit 10.10 to the Company's Current
Report on Form 8-K filed with the Commission on February 8, 2008)
23.1
Consent of Womble Carlyle Sandridge & Rice, PLLC (included in Exhibit 5)
23.2
Consent of Cherry, Bekaert & Holland, L.L.P.
24
Power of Attorney (included in the signature page hereto)
Item 9
.
Undertakings
.
(a)
The undersigned registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a post-effective
amendment to this Registration Statement:
4
Table of Contents
(i) To include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii) To reflect in the prospectus any facts or events arising after the effective date of
the Registration Statement (or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change in the information set
forth in the Registration Statement;
(iii) To include any material information with respect to the plan of distribution not
previously disclosed in the Registration Statement or any material change to such
information in the Registration Statement;
provided
,
however
, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if
the registration statement is on Form S-8, and the information required to be included in a
post-effective amendment by those paragraphs is contained in reports filed with or furnished
to the Commission by the Company pursuant to Section 13 or Section 15(d) of the Exchange Act
that are incorporated by reference in the Registration Statement.
(2) That, for the purpose of determining any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the offering.
(b)
The Company hereby undertakes that, for purposes of determining any liability under the
Securities Act, each filing of the Company's annual report pursuant to Section 13(a) or
Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit
plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by
reference in the Registration Statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial bona fide offering thereof.
(c)
Insofar as indemnification for liabilities arising under the Securities Act may be permitted
to directors, officers and controlling persons of the Company pursuant to the foregoing
provisions, or otherwise, the Company has been advised that in the opinion of the Commission
such indemnification is against public policy as expressed in the Securities Act and is,
therefore, unenforceable. In the event that a claim for indemnification against such
liabilities (other than the payment by the Company of expenses incurred or paid by a director,
officer or controlling person of the Company in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in connection with the
securities being registered, the Company will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the
Securities Act and will be governed by the final adjudication of such issue.
5
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act, MiMedx Group, Inc. certifies that it has
reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has
duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Marietta, State of Georgia, on this 28
th
day of August,
2008.
MIMEDX GROUP, INC.
By:
/s/ John C. Thomas, Jr.
Name:
John C. Thomas, Jr.
Title:
Chief Financial Officer
POWER OF ATTORNEY
Each of the undersigned, being a director and/or officer of MiMedx Group, Inc. (the
"Company"), hereby nominates, constitutes and appoints Thomas W. D'Alonzo and John C. Thomas, or
any one of them severally to be his true and lawful attorney-in-fact and agent and to sign in his
name and on his behalf in any and all capacities stated below, and to file with the Securities and
Exchange Commission (the "Commission"), a Registration Statement on Form S-8 (the "Registration
Statement") relating to the issuance of certain shares of the common stock, $.001 par value, of the
Company in connection with the MiMedx Group, Inc. Assumed 2006 Stock Incentive Plan, the MiMedx, Inc. 2005 Assumed Stock Plan (formerly the SpineMedica Corp. 2005
Employee, Director and Consultant Stock Plan), and the MiMedx, Inc. Assumed 2007 Stock Plan
(formerly the SpineMedica Corp. 2007 Stock Incentive Plan), and to file any and all amendments,
including post-effective amendments, exhibits and other documents and instruments in connection
therewith, to the Registration Statement, making such changes in the Registration Statement as such
attorney-in-fact and agent deems appropriate, and generally to do all such things on his behalf in
any and all capacities stated below to enable the Company to comply with the provisions of the
Securities Act of 1933, as amended (the "Securities Act"), and all requirements of the Commission.
Pursuant to the requirements of the Securities Act, this Registration Statement has been
signed by the following persons in the capacities indicated as of August 28
th
, 2008.
/s/ Thomas W. D'Alonzo
/s/ John C. Thomas, Jr.
Name: Thomas W. D'Alonzo
Name: John C. Thomas, Jr.
Title: Chief Executive Officer
Title: Chief Financial Officer and Secretary
(principal
executive officer and Director)
(principal
financial and accounting officer)
/s/ Steve Gorlin
Name: Steve Gorlin
/s/ Kurt M. Eichler
Name: Kurt M. Eichler
Title: Director
Title: Director
/s/ Charles E. Koob
Name: Charles E. Koob
/s/ Larry W. Papasan
Name: Larry W. Papasan
Title: Director
Title: Director
/s/ Ronald G. Wallace
Name: Ronald G. Wallace
Title: Director
Table of Contents
EXHIBIT INDEX
Number
Description
4.1
Articles of Incorporation of MiMedx Group, Inc. (incorporated by
reference to Exhibit 3.1 to the Company's Current Report on Form 8-K
filed with the Commission on April 2, 2008)
4.2
Bylaws of MiMedx Group, Inc., effective February 29, 2008 (incorporated
by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K
filed with the Commission on April 2, 2008)
5
Opinion of Womble Carlyle Sandridge & Rice, PLLC
10.1
MiMedx Group, Inc. Assumed 2006 Stock Incentive Plan (incorporated by
reference to Exhibit 10.1 to the Company's Current Report on Form 8-K
filed with the Commission on February 8, 2008)
10.2
Declaration of Amendment to MiMedx Group, Inc. Assumed 2006 Stock
Incentive Plan (incorporated by reference to Exhibit 10.2 to the
Company's Current Report on Form 8-K filed with the Commission on
February 8, 2008)
10.3
Declaration of Amendment to MiMedx Group, Inc. Assumed 2006 Stock
Incentive Plan (incorporated by reference to Exhibit 10.66 to the
Company's Current Report on Form 8-K filed with the Commission on July
15, 2008)
10.4
MiMedx Group, Inc. Amended and Restated Assumed 2005 Stock Plan
(formerly the SpineMedica Corp. 2005 Employee, Director and Consultant
Stock Plan)
10.5
MiMedx, Inc. Assumed 2007 Stock Plan (formerly the SpineMedica Corp.
2007 Stock Incentive Plan) (incorporated by reference to Exhibit 10.9
to the Company's Current Report on Form 8-K filed with the Commission
on February 8, 2008)
10.6
Declaration of Amendment to MiMedx, Inc. Assumed 2007 Stock Plan
(formerly the SpineMedica Corp. 2007 Stock Incentive Plan)
(incorporated by reference to Exhibit 10.10 to the Company's Current
Report on Form 8-K filed with the Commission on February 8, 2008)
23.1
Consent of Womble Carlyle Sandridge & Rice, PLLC (included in Exhibit 5)
23.2
Consent of Cherry, Bekaert & Holland, L.L.P.
24
Power of Attorney (included in the signature page hereto)